Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2015
Opana ER regulatory and abuse investigation
A joint MedPage Today–Milwaukee Journal Sentinel investigation examined the troubled approval history and widespread abuse of Opana ER. The reporting was followed by regulatory developments, including the FDA's later action to remove the drug from the market.
2011
Investigation of opioid advocacy funding
MedPage Today and the Milwaukee Journal Sentinel reported on financial relationships between opioid manufacturers and nonprofit organizations involved in pain-treatment advocacy. The investigation included claims concerning undisclosed industry funding and contributed to subsequent Senate scrutiny of opioid prescribing and influence.